For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a study in the July Journal of the American Society of Nephrology (JASN). …

article continues at unknown brought to you by diabetes.medtrials.info and medtrials.info